TickerGuard
Buy Day today: Neutral (54) Mixed market breadth · no major macro event
SVA

Sinovac Biotech Ltd

Healthcare · Biotechnology

6.50$ +0.0% vs. previous close Closing price · As of: Sep 12, 2026

Statements

Balance Sheet

Sinovac Biotech Ltd (SVA) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 8,139 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SVA
Line item Q2 15 Q3 15 Q4 15 Q1 16 Q2 16 Q3 16 Q4 16 Q1 17 Q2 17 Q3 17 Q4 17 Q1 18 Q2 18 Q3 18 Q4 18 Q1 19 Q2 19 Q3 19 Q4 19 Q1 20 Q2 20 Q3 20 Q4 20 Q1 21 Q2 21 Q3 21 Q4 21 Q1 22 Q2 22 Q3 22 Q4 22 Q1 23 Q2 23 Q4 23 Q2 24 Q4 24 Q2 25 Q4 25 Q1 26 Q2 26
218 204 205 205 181 204 211 245 245 211 299 299 308 370 382 382 404 411 433 433 529 659 1,901 1,901 12,628 16,748 16,748 16,748 15,066 14,115 14,115 14,115 13,725 13,658 12,897 12,337 11,987 8,542 8,542 8,139
135 124 128 128 107 126 134 162 162 131 204 204 213 284 283 283 304 313 329 329 338 425 1,560 1,560 11,689 14,915 14,915 14,915 13,115 12,126 12,126 – 11,769 11,831 11,148 10,645 10,377 7,064 7,064 6,624
65 54 63 63 49 54 62 55 55 62 114 114 88 158 149 149 152 157 165 165 141 150 1,041 1,041 6,844 11,609 11,609 11,609 6,858 4,278 4,278 – 1,643 1,270 1,072 335 183 488 488 322
65 54 63 63 49 54 62 55 55 62 114 114 88 177 168 168 171 176 187 187 177 184 1,176 1,176 9,817 13,415 13,415 13,415 11,846 11,313 11,313 – 11,069 11,223 10,575 – – – 5,971 –
44 46 40 40 30 48 50 83 83 50 66 66 100 77 82 82 97 105 98 98 106 170 253 253 1,393 952 952 952 970 609 609 – 500 451 405 301 307 286 313 266
23 21 20 20 22 20 14 18 18 14 20 20 22 25 30 30 33 29 36 36 46 57 106 106 408 376 376 376 267 181 181 – 183 140 154 97 109 94 94 107
68 65 64 64 64 67 67 73 73 76 76 74 56 71 71 83 82 80 81 79 165 197 284 – – – – – – – – – – – – – – – – –
– – – – – – – – 379 352 – 0.0 346 0.0 0.0 440 – – – – – – – – – 446 – – – 338 – – – – – 28 12 13 13 13
10 10 9.6 9.6 9.2 9.1 8.7 8.8 8.8 8.7 9.0 9.0 8.8 8.3 8.4 8.4 8.2 7.8 7.8 7.8 9.0 9.4 9.7 9.7 22 41 41 41 46 80 80 – 74 74 71 184 136 140 140 142
74 66 66 66 58 76 82 96 96 82 122 122 111 78 82 82 92 97 94 94 191 281 781 781 3,498 2,872 2,872 2,872 972 1,402 1,402 – 1,488 1,635 1,390 2,044 5,644 2,145 2,145 1,674
60 51 58 58 51 66 66 78 78 66 93 93 84 58 57 57 70 74 81 81 114 194 680 680 3,308 2,413 2,413 2,413 565 1,092 1,092 – 1,190 1,148 978 1,452 5,001 1,540 1,540 1,091
35 27 33 33 26 32 34 24 24 34 18 18 9.8 3.3 5.3 5.3 7.3 4.7 19 19 22 37 43 43 46 15 15 15 8.0 11 11 – 211 82 182 – – – 231 –
20 18 23 23 22 26 1.8 52 52 1.8 6.8 6.8 68 5.5 47 47 55 55 46 46 71 117 31 31 959 59 59 59 334 20 906 – 820 17 642 12 590 16 16 250
– 0.8 0.8 2.7 3.0 6.0 9.4 12 12 22 15 20 15 11 11 8.9 6.7 7.8 1.4 1.4 16 23 8.3 – 19 – – – – – 12 – 11 178 130 164 233 265 – 233
127 124 123 123 112 115 116 130 130 116 151 151 163 253 259 259 267 266 284 284 280 306 746 746 5,873 9,327 9,327 9,327 9,468 8,921 8,921 – 8,665 8,709 8,649 8,262 4,370 4,439 4,439 4,505
-6.4 -8.0 -7.0 -7.0 -17 -13 -12 -1.1 -1.1 -12 9.1 9.1 23 24 25 25 36 42 49 49 44 54 144 144 5,250 7,142 7,142 7,142 7,623 7,226 7,226 – 7,240 7,119 7,108 6,838 2,859 2,816 2,816 2,756
56 56 57 57 57 57 57 57 57 57 57 58 60 71 83 83 114 99 99 99 99 114 114 114 114 114 – – 114 100 100 114 114 100 72 72 72 72 – 72

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: September 12, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?